OVERVIEW OF DIABETIC NEUROPATHY
Main Article Content
Keywords
Diabetic neuropathy, Pathophysiology, Diagnosis, Prevention, and control
Abstract
Background: Diabetic neuropathy, impacting both type 1 and type 2 diabetes patients, stems from prolonged high blood sugar damaging nerves, leading to diverse symptoms like discomfort and numbness. Various physiological mechanisms, including hyperglycemia and prediabetes, contribute to its development, while psychological factors also impact patients' quality of life. Diagnosis involves comprehensive evaluations, including nerve conduction studies and skin biopsy. Prevention strategies focus on strict glycemic control, lifestyle adjustments, and early intervention, with exercise, neurostimulation devices, and nutraceuticals showing promise in managing neuropathic pain. Pharmaceutical treatments alleviate symptoms but may cause adverse effects. Herbal remedies, like flavonoids, offer alternative therapeutic options with potential benefits in reducing inflammation and oxidative stress, presenting a multifaceted strategy for diabetic neuropathy management.
Aim: to understand diabetic neuropathy, covering its causes, symptoms, pathophysiology, diagnosis, control and prevention, and treatment options to improve treatment outcomes.
Methods: a comprehensive review of Diabetic neuropathy and therapy. The PUBMED and Google Scholar search engines were the main databases used for the search process, with articles collected from 2007 to 2022.
Conclusion: Diabetic neuropathy, prevalent in both type 1 and type 2 diabetes, results from prolonged high blood glucose levels damaging nerves. Symptoms vary from discomfort to numbness and autonomic issues. Prediabetes is also linked to neuropathy, stressing early detection. Pathophysiologically, factors like glycemic dysregulation and oxidative stress contribute to nerve damage. Diagnosis involves nerve conduction studies and clinical evaluation, though early detection challenges persist. Prevention emphasizes glycemic control, lifestyle adjustments, and emerging therapies like neurostimulation. Medications offer symptom relief, while herbal remedies and flavonoids show promise. Managing diabetic neuropathy requires a multifaceted approach integrating traditional and emerging treatments for improved patient outcomes and quality of life.
References
2. Sharma P, Rani N, Gangwar A, Singh R, Kaur R, Upadhyaya K. Diabetic Neuropathy: A Repercussion of Vitamin D Deficiency. Current Diabetes Reviews. 2023;19(6):80-91.
3. Varma A, Sharma K, Sharma S. Evaluation of Diabetic Neuropathies. 2022;2(1):9-14.
4. Assunção A, Campos D, Marques R, Cunha I, Santos P, Martins A, et al. The impact of demographic and clinical characteristics on diabetic painful neuropathy %J Romanian Journal of Internal Medicine. 2020;58(1):13-9.
5. Mawaddah M, Susmiati S, Lenggogeni DPJRiNJ. Gambaran Karakteristik Pasien Dengan Neuropati Diabetik Pada Diabetes Melitus Tipe 2. 2022;5(3):207-13.
6. Khan MD, Yousaf H, Umar M, Zaib MS, Qazi S, Irshad K, et al. Impact of diabetes mellitus on nerves. International Journal of Research in Medical Sciences. 2020;8(10):3453-6.
7. Fujita Y, Murakami T, Nakamura A. Recent Advances in Biomarkers and Regenerative Medicine for Diabetic Neuropathy. 2021;22(5):2301.
8. Mushabab A, Lukman FO, Bappa A, Magaji GT, Abubakar J, Mohammed A, et al. Disease-specific quality of life in patients with diabetic neuropathy. Saudi Medical Journal. 2022;43(4):408.
9. Davoudi M, Rezaei P, Rajaeiramsheh F, Ahmadi SM, Taheri AA. Predicting the quality of life based on pain dimensions and psychiatric symptoms in patients with Painful diabetic neuropathy: a cross-sectional prevalence study in Iranian patients. Health and Quality of Life Outcomes. 2021;19(1):49.
10. Eid SA, Rumora AE, Beirowski B, Bennett DL, Hur J, Savelieff MG, et al. New perspectives in diabetic neuropathy. Neuron. 2023;111(17):2623-41.
11. Singh A, Kukreti R, Saso L, Kukreti S. Mechanistic Insight into Oxidative Stress-Triggered Signaling Pathways and Type 2 Diabetes. 2022;27(3):950.
12. Alles SRA, Smith PA. Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets. 2021;2.
13. Kang SMJTJoKD. Pathogenesis and Treatment of Diabetic Peripheral Neuropathy. 2022;23(4):222-9.
14. Mahmood F, Ahmad SJSJAMS. Pathophysiology and Pharmacotherapeutics of Diabetic Neuropathy: A Review. 2022;12:2096-102.
15. Jankovic M, Novakovic I, Nikolic D, Mitrovic Maksic J, Brankovic S, Petronic I, et al. Genetic and Epigenomic Modifiers of Diabetic Neuropathy. 2021;22(9):4887.
16. Katagi M, Terashima T, Okano J, Urabe H, Nakae Y, Ogawa N, et al. Hyperglycemia induces abnormal gene expression in hematopoietic stem cells and their progeny in diabetic neuropathy. 2014;588(6):1080-6.
17. Witzel I-I, Jelinek HF, Khalaf K, Lee S, Khandoker AH, Alsafar HJFie. Identifying common genetic risk factors of diabetic neuropathies. 2015;6:141587.
18. Chiaramonte R, Romano M, Vecchio M. A Systematic Review of the Diagnostic Methods of Small Fiber Neuropathies in Rehabilitation. 2020;10(9):613.
19. Koçer A. How to diagnose neuropathy in diabetes mellitus? The European Research Journal. 2018;4(2):55-69.
20. Goyal M, Mittal A, Samuel AJJJoDMIoMSU. Diagnostic methods used in patients with diabetic peripheral neuropathy: With special importance on radiological methods. 2022;17(2):472-8.
21. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa MJNEJoM. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. 1995;333(2):89-94.
22. Rad MM, Soheilipour FS, Baradaran HR, Rimaz SR, Marvasti SK, Taslimi H, et al. The influence of diabetic family history on the development of neuropathy in type 2 diabetic patients: a survival analysis. 2020;27(1):25-33.
23. Ansari P, Hannan JMA, Azam S, Jakaria M. Challenges in Diabetic Micro-Complication Management: Focus on Diabetic Neuropathy. 2021;1(3):175-86.
24. Gandhi M, Fargo E, Prasad-Reddy L, Mahoney KM, Isaacs DJDiC. Diabetes: how to manage diabetic peripheral neuropathy. 2022;11.
25. Smith S, Normahani P, Lane T, Hohenschurz-Schmidt D, Oliver N, Davies AH. Prevention and Management Strategies for Diabetic Neuropathy. 2022;12(8):1185.
26. Zilliox LA, Russell JW. Physical activity and dietary interventions in diabetic neuropathy: a systematic review. Clinical Autonomic Research. 2019;29(4):443-55.
27. Qureshi Z, Ali MN, Khalid M. An Insight into Potential Pharmacotherapeutic Agents for Painful Diabetic Neuropathy. Journal of Diabetes Research. 2022;2022:9989272.
28. Arora K, Tomar PC, Mohan V. Diabetic neuropathy: an insight on the transition from synthetic drugs to herbal therapies. Journal of Diabetes & Metabolic Disorders. 2021;20(2):1773-84.
29. Chung G, Kim SK. Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine. 2022;14(7):1407.
30. Asgary S, Naderi GA, Sarraf-Zadegan N, Vakili R. The Inhibitory Effects of Pure Flavonoids on in Vitro Protein Glycosylation. Journal Of Herbal Pharmacotherapy. 2002;2(2):47-55.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
Ali Nasser Mansour Shammakhi
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Tareq Ahmed Ali Khormi
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Ghason Ali A Torki
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Mohammed Ali Hussein Alhazmi
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Ibraheem Sindi Shetifi
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Majed Hameed Alharbi
General Directorate Of Health Affairs – Medina– Saudi Arabia
Abualgassam Nasseer Mohmmed Zwogan
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Khaled Mossa Mohsen Mashi
Eradah Hospital For Mental Health – Jazan – Saudi Arabia
Nahla Shaker Saati
Alwafaa Primary Healthcare – Jeddah– Saudi Arabia
Saleh Mohammed Shami
Eradah And Mental Health Complex – Jeddah– Saudi Arabia
Feher Mohammed Alturkistani
King Abdulaziz Hospital - Jeddah– Saudi Arabia
Ahmed Sameer Munshi
King Abdulaziz Hospital - Jeddah– Saudi Arabia
Mosaad Abdullah Alqarni
King Abdulaziz Hospital - Jeddah– Saudi Arabia
Adel Hamad Khardali
Eradah Hospital For Mental Health – Jazan – Saudi Arabia